Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future

Click to increase image sizeClick to decrease image size

Declaration of interest

N. Balato has served as a speaker, consultant, advisory board member for, or has received research grants from: Abbott, Janssen-Cilag, Merck Serono, Schering-Plough, Wyeth. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper was not funded.